Скачать или смотреть Navigating CBD Legality and Quality - Part 1

Awesome summary based on this great publication by C Michael White (https://pubmed.ncbi.nlm.nih.gov/30730...)

In 2018, Epidiolex, a CBD-based drug for epilepsy, was classified as Schedule V, indicating a low abuse risk. However, other CBD products remain Schedule I, highlighting high abuse risk and limited medical value, pending FDA approval. The legal landscape varies across states, with some allowing medical cannabis use under specific laws. This scenario creates a challenge for clinicians to stay informed about state-specific CBD regulations.

Part 2, Stay tuned for more!
#CBD #Quality #Safety #BreakTheStigma #FactVsFiction #InformedChoices #MindfulConsumption #ChallengingPerceptions #EducateYourself #Empowerment #CannabisResearch #CBDResearch #Shorts



Code: 2XJN8Y1GEAEEQCAV